Circulating adropin and vascular endothelial growth factor receptor-2 levels in age-related macular degeneration and T2DM patients—A cross-sectional study
Background: Macular drusen formation and angiogenesis are the two chief processes associated with age-related macular degeneration. Adropin and vascular endothelial growth factor receptor-2 (VEGFR-2) may be involved in these pathologies. By altering lipid metabolism, adropin may contribute in the ea...
Main Authors: | Areekulangara Neethu, Kuppuswami Jayashree, Gandhipuram Periyasamy Senthilkumar, K Ramesh Babu, Mehalingam Vadivelan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2020;volume=9;issue=9;spage=4875;epage=4879;aulast=Neethu |
Similar Items
-
Serum adropin level in wet-type age-related macular degeneration
by: Zahra Saeedi-Maleki, et al.
Published: (2024-03-01) -
Serum vascular endothelial growth factor receptor-2 and adropin levels in age-related macular degeneration
by: Nurgül Örnek, et al.
Published: (2016-04-01) -
Adropin as an indicator of T2DM and its complications
by: Hu Zhang, et al.
Published: (2022-11-01) -
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
by: Daniel Ahmed, et al.
Published: (2020-09-01) -
Subthreshold Nano-Second Laser Treatment and Age-Related Macular Degeneration
by: Amy C. Cohn, et al.
Published: (2021-01-01)